SBIR Phase I: User Application and Backend Portal to Enhance and Measure Addiction Treatment and Recovery Efficacy

这个小企业创新研究（SBIR）第一阶段项目的更广泛的影响/商业潜力是，根据需要调查增强核心个人用户应用程序和商业后端门户产品的可行性，以增强和衡量创新成瘾治疗和恢复支持工具的功效。如果成功，该投资将使医疗保健利益相关者（例如个人、成瘾和精神健康机构和提供者、健康研究人员和大学、政府机构和支付方）能够利用技术增强的成瘾治疗创新，如正念训练、应急管理、药物辅助治疗、同伴支持和适应性干预，有望改善健康结果和交付效率。拟议的创新将有助于确定开发、测试和商业化创新技术的可行性，这些技术可提高现有卫生信息技术解决方案的效力，并为对开发、提供、并评估在研究和交付环境中有效的成瘾治疗和康复支持服务，以及在公共和私人成瘾康复交付环境中产生可观收入的能力。拟议中的项目将需要快速组装技术基础，然后测试支持部署和评估新的、基于证据的成瘾治疗策略和康复干预措施的可行性。有四个关键的研究目标：(1)设计、开发和测试一种机制，以创建具有统计意义的队列；(2)衡量参与者恢复和清醒成功的识别和测试方法；（三）开展内部治理运动；(4)创建研究人员应用程序接口，使成瘾研究人员能够与系统连接。目前，还没有商业上可行的平台来展示、实施和跟踪最佳疗法和工具在应用环境中的效果。第一阶段将侧重于确定该技术的可行性，以解锁可被临床验证为成功的科学干预措施，以便扩大第二阶段的工作，以证明该系统向用户提供单变量或双变量治疗活动的能力，同时建立临床疗效，以改善健康结果，足以通过具有成本效益的治疗方案支持全国范围内的干预措施。

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to investigate the feasibility of enhancing the core individual user application and commercial backend portal products as required to enhance and measure the efficacy of innovative addiction treatment and recovery support tools. If successful, the investment will enable healthcare stakeholders (e.g., individuals, addiction and mental health institutions and providers, health researchers and universities, government agencies, and payers) to leverage technology-enhanced addiction treatment innovations such as mindfulness training, contingency management, medication-assisted treatment, peer support, and adaptive interventions that show promise for improving health outcomes and delivery efficiencies. The proposed innovation will help to determine the feasibility of developing, testing, and commercializing innovative technologies that improve the efficacy of existing health IT solutions and to create new solutions for the range of stakeholders exhibiting increasingly high demand for effective interventions and tools required to develop, provide, and assess effective addiction treatment and recovery support services in a mix of research and delivery settings and the ability to generate significant revenue across the mix of public and private addiction recovery delivery settings.The proposed project will entail rapidly assembling the technical foundation and then testing the feasibility of supporting deployment and assessment of novel, evidence-based addiction treatment strategies and recovery interventions. There are four key research objectives: (1) design, develop, and test a mechanism to create statistically significant cohorts; (2) discern and test methods to measure participant recovery and sobriety success; (3) conduct internal treatment campaigns; and, (4) create a researcher application program interface to enable addiction researchers to connect with the system. Currently, there is no commercially viable platform for surfacing, implementing, and tracking the efficacy of optimal therapies and tools in an application environment. Phase I will focus on determining the feasibility of this technology for unlocking scientific interventions that can be clinically validated as successful in order to expand work in phase II to prove the capacity of this system to deliver single or bivariate therapy campaigns to users while also establishing the clinical efficacy for improving health outcomes sufficient to support interventions nationwide through cost-effective treatment solutions.